RxDoctor Payments Data

Patricia Waddell

Family · Jefferson City, TNNPI 1689846271

Payments from drug & device makers

$9,165in general payments, 2019–2025

Across 521 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$805
  • Pfizer$726
  • UCB, Inc.$548
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$8,92397%
  • Education$2423%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,165 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,134
Medicare patients
164
Services billed
1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab194$1,372,982
Orencia ClickjectAbatacept76$441,960
Enbrel SureclickEtanercept46$378,135
Enbrel MiniEtanercept44$339,720
RinvoqUpadacitinib49$314,485
Xeljanz XrTofacitinib Citrate44$264,035
Humira(Cf)Adalimumab33$255,469
Taltz AutoinjectorIxekizumab32$228,019
XeljanzTofacitinib Citrate39$217,168
OtezlaApremilast37$152,165
KineretAnakinra13$70,623
Hydroxychloroquine Sulfate933$36,410
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen793$15,742
MethotrexateMethotrexate Sodium530$11,730
Pregabalin282$5,956

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Humira(Cf)$2,362$569,95482 claims
PfizerXeljanz$726$217,16839 claims
AmgenOtezla$1,406$152,16537 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Jefferson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →